Serbia (RS)

Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA (2020) Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, Vagionas A, Hohenforst-Schmidt W, et al. Journal article Broadband spatio-temporal propagation characteristics of Airy plasmons (2020) Singh A, Falkner M, Steinert M, Kaiser T, Isic G, Pertsch T Journal article Studies of the stability, nucleophilic substitution reactions, DNA/BSA interactions, cytotoxic activity, DFT and molecular docking of some tetra- and penta-coordinated gold(iii) complexes (2020) Radisavljevic S, Kesic AD, Cocic D, Puchta R, Senft L, Milutinovic M, Milivojevic N, Petrovic B Journal article Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study (2020) Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airo P, Valentini G, et al. Journal article Experimental and quantum chemical study оn the DNA/protein binding and the biological activity of a rhodium(iii) complex with 1,2,4-triazole as an inert ligand (2020) Petrović A, Živanović M, Puchta R, Ćoćić D, Scheurer A, Milivojevic N, Bogojeski J Journal article Combined Raman and AFM detection of changes in HeLa cervical cancer cells induced by CeO2nanoparticles-molecular and morphological perspectives (2020) Miletic M, Askrabic S, Rueger J, Vasic B, Koricanac L, Mondol AS, Dellith J, et al. Journal article CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al. Conference contribution PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al. Conference contribution LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Rech J, Tascilar K, Schenker H, Hagen M, Sergeeva M, Selvakumar M, Konerth L, et al. Conference contribution EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020) Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, et al. Journal article